-
公开(公告)号:US11655245B2
公开(公告)日:2023-05-23
申请号:US16903020
申请日:2020-06-16
Applicant: Genentech, Inc.
Inventor: Jack Alexander Terrett , Huifen Chen , Lea Constantineau-Forget , Robin Larouche-Gauthier , Luce Lépissier , Francis Beaumier , Martin Déry , Chantal Grand-Maître , Claudio Sturino , Matthew Volgraf , Elisia Villemure
IPC: A61K31/427 , A61P11/00 , A61P23/00 , A61P25/00 , A61P29/00 , C07D513/04 , C07D473/30 , C07D487/04 , C07D498/04 , C07D471/04 , C07D413/14
CPC classification number: C07D413/14 , A61K31/427 , A61P11/00 , A61P23/00 , A61P25/00 , A61P29/00 , C07D471/04 , C07D473/30 , C07D487/04 , C07D498/04 , C07D513/04
Abstract: The invention relates to methods of using compounds formula I:
and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.-
公开(公告)号:US11648317B2
公开(公告)日:2023-05-16
申请号:US16383478
申请日:2019-04-12
Applicant: Genentech, Inc.
Inventor: Ankit R. Patel , Jun Liu
IPC: A61K39/395 , A61K47/68 , A61J1/10 , A61K47/22 , A61K47/26 , A61K47/34 , A61K47/10 , A61K47/02 , A61K47/54 , A61K38/08 , C07K16/28 , A61K47/14
CPC classification number: A61K47/6811 , A61J1/10 , A61K38/08 , A61K47/02 , A61K47/10 , A61K47/14 , A61K47/22 , A61K47/26 , A61K47/34 , A61K47/542 , A61K47/6873 , C07K16/2803 , C07K2317/24 , C07K2317/56
Abstract: The disclosure provides stable pharmaceutical compositions comprising an anti-CD79b immunoconjugate and a surfactant. The disclosure also provides methods for using such compositions for the treatment of cancer.
-
公开(公告)号:US20230143860A1
公开(公告)日:2023-05-11
申请号:US17986737
申请日:2022-11-14
Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
Inventor: Xiao LI , Jian DAI , Fabien GAIRE
CPC classification number: G06T7/0012 , G16H50/20 , G06V20/698 , G06T2207/10024 , G06T2207/10056 , G06T2207/30096
Abstract: Systems and methods relate to processing digital pathology mages. More specifically, depictions of objects of a first class (e.g., lymphocytes) and depictions of objects of a second class (e.g., tumor cells) are detected. Locations of each biological object depiction are identified, which are used to generate multiple spatial-distribution metrics that characterize where depictions of objects of a first class are located relative to objects of a second class. The spatial-distribution metrics are used to generate a result corresponding to a predicted biological state of or a potential treatment of a subject. For example, the result may predict whether and/or an extent to which lymphocytes have infiltrated a tumor, whether checkpoint blockade therapy would be an effective treatment for the subject, and/or whether a subject is eligible for a clinical trial.
-
134.
公开(公告)号:US20230143532A1
公开(公告)日:2023-05-11
申请号:US17938835
申请日:2022-10-07
Inventor: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert Mantei , Todd M. Hansen
IPC: C07D401/12 , C07D401/14 , C07D519/00 , C07D471/04 , C07D209/82 , C07D403/12 , A61K31/496
CPC classification number: C07D401/12 , A61K31/496 , C07D209/82 , C07D401/14 , C07D403/12 , C07D471/04 , C07D519/00 , Y02A50/30
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
-
公开(公告)号:US20230135258A1
公开(公告)日:2023-05-04
申请号:US17914737
申请日:2021-03-23
Applicant: Genentech, Inc.
Inventor: Jasmine Patil , Neha Sutheekshna Anegondi , Alexandre J Fernandez Coimbra , Simon Shang Gao , Michael Gregg Kawczynski
Abstract: A method, system, and computer program product for evaluating a geographic atrophy lesion. An image of a geographic atrophy (GA) lesion is received. A first set of values is determined for a set of shape features using the image. A second set of values is determined for a set of textural features using the image. GA progression for the GA lesion is predicted using the first set of values and the second set of values.
-
公开(公告)号:US20230133817A1
公开(公告)日:2023-05-04
申请号:US18063173
申请日:2022-12-08
Applicant: RQX Pharmaceuticals, Inc. , Genentech, Inc.
Inventor: Yongsheng Chen , Peter Andrew Smith , Tuker Curran Roberts , Robert I. Higuchi , Prasuna Paraselli , Michael F.T Koehler , Jacob Bradley Schwarz , James John Crawford , Cuong Q. Ly , Emily J. Hanan , Huiyong Hu , Zhiyong Yu
IPC: C07D245/04 , C07K5/02 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , A61K31/496 , A61K31/546 , C07K5/087 , C07K5/103 , C07K5/11 , C07K7/06 , C07K7/08 , C07K5/113 , C07K9/00 , C07K5/117 , A61K31/395 , A61K31/431 , A61K31/407 , A61K31/43 , A61K31/4196 , A61K31/545 , C07K5/09 , A61P31/04 , A61K9/00
Abstract: Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
-
公开(公告)号:US20230123110A1
公开(公告)日:2023-04-20
申请号:US17829750
申请日:2022-06-01
Applicant: GENENTECH, INC.
Inventor: Jillian Smith , Janice Smith , Geoff Kerchner
IPC: C07K16/18 , A61K31/185 , A61P25/28 , A61K31/4745 , C07K16/00 , A61K31/13 , A61K31/4418 , A61K31/405 , A61K9/00 , A61K31/455 , A61K39/395 , A61K31/519 , A61K45/06
Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.
-
公开(公告)号:US20230120018A1
公开(公告)日:2023-04-20
申请号:US18058110
申请日:2022-11-22
Applicant: Genentech, Inc.
Abstract: The present disclosure relates to polypeptide degradation, and in particular to techniques for predicting the likelihood that a peptide bond for a given polypeptide molecule is susceptible to a cleavage reaction. Particularly, aspects of the present disclosure are directed to generating a representation of a polypeptide, performing a molecular-dynamics simulation using the representation to obtain a set of polypeptide conformations, determining, for each polypeptide conformation, a spatial characteristic of an amino acid, estimating a nucleophilic attack distance of each polypeptide conformation based on the spatial characteristic, identifying a reactive conformation that is susceptible to a cleavage reaction based on the nucleophilic attack distance of each polypeptide conformation, determining a free energy of the spatial characteristic of the amino acid in the reactive conformation; and predicting a probability of the side chain of the amino acid being trapped in the reactive conformation based on the free energy.
-
公开(公告)号:US11612606B2
公开(公告)日:2023-03-28
申请号:US16592502
申请日:2019-10-03
Applicant: Genentech, Inc.
Inventor: Jun Liang , Rohan V. Mendonca , Michael Siu , John Tellis , Weiru Wang , BinQing Wei , Bryan Chan , Edna F. Choo , Joy Drobnick , Lewis J. Gazzard , Timothy Heffron
IPC: A61K31/5383 , A61K31/4725 , C07D498/04 , C07D498/08 , A61K31/4375 , C07D491/052 , A61K31/436 , A61K31/551 , C07D471/04 , A61K31/439
Abstract: 3-Carbonylamino-8-aminoisoquinoline compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the 3-carbonylamino-8-aminoisoquinoline compounds.
-
公开(公告)号:US20230090177A1
公开(公告)日:2023-03-23
申请号:US17994638
申请日:2022-11-28
Applicant: GENENTECH, INC.
Inventor: James Thomas Koerber , Yonglian Sun
IPC: G01N33/531 , G01N33/566 , C07K16/18 , C07K16/10
Abstract: The present disclosure relates to improved methods and compositions for making extracellular vesicles (EVs). The present disclosure also relates to novel EV-based ELISA assays and kits for performing such assays, as well as methods of producing antibodies to particular antigens using EVs comprising membrane-bound antigen.
-
-
-
-
-
-
-
-
-